Open Access Article
Zuhair Jamain
*ab,
Melati Khairuddean*b and
Tay Guan-Sengc
aFaculty of Science and Natural Resources, Universiti Malaysia Sabah (UMS), 88400 Kota Kinabalu, Sabah, Malaysia. E-mail: zuhairjamain@ums.edu.my
bSchool of Chemical Sciences, Universiti Sains Malaysia (USM), 11800 Penang, Malaysia. E-mail: melati@usm.my
cSchool of Industrial Technology, Universiti Sains Malaysia (USM), 11800 Penang, Malaysia
First published on 4th August 2020
Nucleophilic substitution reaction between 4-hydroxybenzaldehyde and hexachlorocyclotriphosphazene, HCCP formed hexakis(4-formlyphenoxy)cyclotriphosphazene, 1. Intermediates 2a–e was formed from the alkylation reaction of methyl 4-hydroxybenzoate with alkyl bromide which further reduced to form benzoic acid intermediates. Further reaction of 2a–e and other substituted benzoic acid formed 3a–h, which then reduced to give subsequent amines, 4a–h. Other similar reaction was used to synthesis 4i. Condensation reaction between 1 and 4a–i yielded hexasubstituted cyclotriphosphazene compounds, 5a–i having Schiff base and amide linking units, and these compounds consist of different terminal substituents such as heptyl, nonyl, decyl, dodecyl, tetradecyl, hydroxy, carboxy, chloro, and nitro groups, respectively. Compound 5j with amino substituent at terminal end was formed from the reduction of 5i. All the intermediates and compounds were characterized using Fourier Transform Infrared (FT-IR), Nuclear Magnetic Resonance (NMR) and CHN elemental analysis. Mesophase texture of these compounds were determined using Polarized Optical Microscope (POM) and their mesophase transition were further confirmed using Differential Scanning Calorimetry (DSC). Only compounds 5a–e with alkoxy chains exhibited smectic A phase while other intermediates (1, 2a–e, 3a–h, and 4a–i) and final compounds (5f–j) are found to be non-mesogenic with no liquid crystal behaviour. The confirmation of the identity of the SmA phase was determined using XRD analysis. The study on the structure–properties relationship was conducted in order to determine the effect of the terminal group, length of the chains and linking units to the mesophase behaviour of the compounds. Moreover, the fire retardant properties of these compounds were determined using Limiting Oxygen Index (LOI) testing. Polyester resin with LOI value of 22.53% was used as matrix for moulding in the study. The LOI value increased to 24.71% when this polyester resin incorporated with 1 wt% of HCCP. Generally, all the final compounds showed a positive results with LOI value above 27% and the highest LOI value was belonged to compound 5i with 28.53%. The high thermal stability of the Schiff base molecules and the electron withdrawing group of the amide bonds and nitro group enhanced the fire retardant properties of this compound.
Liquid crystal (LC) is an anisotropic material with flowing properties (liquid) as well as ordered (solid) and optical properties.7 Since it has the features of both fluid and solid, it became an important intermediate phase or mesomorphic phase.8 LC of organic compounds is divided into two categories which are lyotropic and thermotropic LC. Thermotropic LC are influenced by the change in temperature while lyotropic LC which are composed mainly of the amphiphilic bilayer are concentration and temperature dependant.9,10
The influence of different elements and the extended chemical subunits on the molecules allows the construction of the targeted liquid crystal compounds. The molecular shape and the terminal chain length are the key variables in designing new liquid crystal compounds with specific types of molecular organization in a particular range of temperature.11–13 Linking units are normally structural units that connect one core to another, which maintain the linearity of the core while being compatible with the rest of the structure. A linking unit between ring systems is to increase the length of the molecules and to alter the polarisability and flexibility of the molecules.14 Schiff base is one the interesting linking unit that provide a stepped core structure which can maintain the linearity of the molecules to provide high stability. This enables the mesophase formation whereby the phase transition temperature and the physical properties changes are usually contributed by the linking group.15 On the other hand, the formation of an amide linking unit led to higher rigidity due to the presence of the partial double bond character of the C–N bond which resulted in higher transition and clearing temperatures of the mesogens.16 The partial double bond in C–N bond reduces the coplanarity of the molecule and the broadening of the rigid core, which resulted in the molecules that favoured a lamellar arrangement in the smectic layer.17 The correlation between the molecular structure such as core system, linking units and terminal groups are the most important aspect in liquid crystal field.
Jiménez et al. (2011) reported the synthesis of hexasubstituted cyclotriphosphazene derivatives attached to the side arms with an ester linking unit but different terminal chains. The formation of the mesophase depended on the balance between the rigid core and the flexible terminal chains while the type and stability of the mesophase were determined by the space filling and nanosegregation. The combination of these factors along with tailoring of the interface curvature by the space requirements of the incompatible molecular blocks will determines the difference mesophase morphologies of these cyclotriphosphazene molecules.18 Moreover, He et al. (2013) have synthesized the room temperature columnar mesogens of hexasubstituted cyclotriphosphazenes compounds with Schiff base and ether linking units. They found out that increasing the chain length increased the melting point and decreased the clearing point.19
On the other side, HCCP also known to be used as a molecule to have high fire retardancy. Fire retardant materials play an important role in protecting property from damage. Fire retardation occurred due to the removal of heat from the materials that can burn and the formation of char during the fire which will interrupt the contact from combustion.20 Generally, materials with limiting oxygen index (LOI) value above 26% are considered fire retardant and self-extinguishing behaviour can be observed.21,22 Zhang et al. (2012) have synthesized and studied the fire retardant properties of hexakis(4-nitrophenoxy)cyclotriphosphazene on poly(ethylene terephthalate). The LOI value of poly(ethylene terephthalate) increased from 26.8% to 35.1% when 10 wt% of this compound was added.23 Moreover, Rong et al. have conducted two independent studies on the cyclotriphosphazene core system in 2015 and 2017. Their findings showed that the modification of cyclotriphosphazene core system able to induce the thermal stability, which enhances the fire resistance of the compounds.24,25
Therefore, the interest of the research is to gain a better insight of the structure–properties relationship of these types of compounds. Addition of HCCP into a compound is to increase the resistance of the material towards ignition. Both liquid crystal and fire retardant properties were studied. Thus, this research focused on the preparation of a series of hexasubstituted cyclotriphosphazene derivatives with Schiff base and amide linking units that bore a different terminal end. In this work, polyester resin will be used as a medium for moulding in order to study the fire retardant of the compounds. Only 1 wt% is added in this resin in order to achieve highest fire retardancy with less additive usage. Polyester resin is chosen due to good mechanical properties, fast curing, low cost and more sensitive to elevated temperatures.
![]() | ||
| Scheme 1 Formation of intermediates (1, 2a–e, 3a–h, and 4a–i) and hexasubstituted cyclotriphosphazene compounds, 5a–i. | ||
(H–C
O), 1700 (C
O), 1595 (C
C), and 1205 cm−1 (C–O). The IR data of intermediates 2a–e showed the absorption bands at 3250 (O–H stretching), 2852 and 2921 (Csp3–H stretching), 1680 (C
O stretching), 1605 (C
C stretching), and 1250 cm−1 (C–O stretching). Intermediates 3a–h were successfully synthesized as evident from the appearance of a new band at 3300 cm−1 (N–H stretching) of the amide linkage. Further reduction of intermediates 3a–h gave rise to intermediates 4a–h with the appearance of two absorption bands at 3200 and 3400 cm−1 (N–H stretching) in the IR spectra of the latter. Intermediate 4i which was synthesized using other method also showed similar bands at 3207 and 3408 cm−1 (N–H stretching). Other bands at 1690 (C
O), 1590 (C
C), 1250 (C–O), and 1175 cm−1 (C–N) stretching were observed in both intermediates 3a–h and 4a–i. The diagnostic bands at 3200 and 825 cm−1 were attributable to the O–H stretching and C–Cl bending, respectively in 3f–g and 4f–g.
The overlay IR spectra of compounds 5a–j with Schiff base and amide linking units are shown in Fig. 1. The reaction between hexasubstituted cyclotriphosphazene benzaldehyde, 1 and intermediates 4a–i gave 5a–i. The appearance of the expected absorption band at 1644 cm−1 for C
N stretching confirmed the successful condensation reaction of intermediates 4a–i. Further reduction of compound 5i produced compound 5j with the appearance of two-spike at 3207 and 3416 cm−1 (N–H stretching). Besides, all the compounds showed the absorption band for the N–H stretching of the amide linkage at 3365 cm−1.
On the other hand, compounds 5f and 5g showed the overlapping of the absorption bands for hydroxy (–OH) and N–H stretching of the amide groups because peak broadening of the O–H stretching. Other absorptions bands were observed at 1691 cm−1 for the carbonyl (C
O) stretching, and also at 1592, 1254, and 1178 cm−1 for C
C, C–O, and C–N stretching, respectively. As usual, the diagnostic bands at 2851 and 2919 cm−1 which corresponding to the Csp3–H symmetrical and asymmetrical stretching of alkoxy chains can be observed in compounds 5a–e. In addition, the bending at 819 cm−1 was assigned to the C–Cl bending in compound 5h. The absorption bands from the cyclotriphosphazene ring, P
N stretching appeared at 1197 cm−1, while P–O–C bending was located at 977 cm.
The 1H-NMR data of 2a–e revealed similar pattern with two doublets assigned for two aromatic protons, while all the peaks in the upfield region were assigned to the aliphatic protons of heptyl, nonyl, decyl, dodecyl, and tetradecyl chains. The 13C-NMR data of 2a–e showed the carbon signals for aromatic ring and aliphatic chains. The signal for the aliphatic carbons displayed similar pattern but only differed in the intensity, which due to the different length in the carbon chains. The carboxy carbon for 2a–e showed a signal at the most downfield region at δ 168.78, 169.36, 168.78, 167.95, and 169.18 ppm, respectively. No signal for the methyl observed in both spectra indicating that the reduction reaction was a success.
Meanwhile, the 1H-NMR data of intermediates 3a–h showed a similar pattern with a singlet corresponded to the amide proton (N–H) in the most downfield region at δ 10.61, 10.22, 10.33, 10.25, 10.25, 9.72, 11.06, and 9.90 ppm, respectively. Both the 1H and 13C-NMR data showed the presence of four doublets of protons and eight carbons signal for the aromatic ring. The reduction of intermediates 3a–h to 4a–h showed the appearance of N–H signals of the amine group at δ 5.00 ppm in the 1H-NMR spectra. For final compound, 5c was used to represent the structure confirmation in the series. The structure of compound 5c with complete atomic numbering is illustrated in Fig. 2.
In the 1H NMR spectrum of compound 5c (Fig. 3), two singlets in the downfield region at δ 9.82 (H5) and δ 8.65 ppm (H10) were assigned to the amide and azomethine protons, respectively. Five distinguishable doublets located within δ 7.02–7.96 ppm were assigned to the aromatic protons. One of these signals with integrating to four protons were overlapped and appeared as a triplet (H3 and H13).
However, the effect of the amide group as an electron withdrawing group which caused the electron density of the molecule to decrease, forced H8 to experience more deshielding effect compared to H7 and H14, which was more deshielded than H2. An oxymethylene proton, H16 appeared as a triplet at δ 4.08 ppm and all the methylene protons (H17–H24) were assigned in the region of δ 1.27–1.78 ppm. A triplet in the most upfield region was assigned to H25 at δ 0.88 ppm.
The 13C NMR spectrum of compound 5c (Fig. 4a) showed 23 carbon signals comprising of one azomethine, seven quaternary, six aromatics, one oxymethylene, seven methylene, and one methyl carbons. DEPT 90 (Fig. 4b) and DEPT 135 (Fig. 4c) experiments were conducted to distinguish the types of carbons. In the DEPT 90 spectrum, the azomethine carbon, C5 was observed at δ 158.09 ppm while the aromatic carbons resonated at δ 130.47 (C3), 129.94 (C13), 129.28 (C8), 121.75 (C7), 121.69 (C14), and 114.81 ppm (C2).
For others homologues, the 1H and 13C NMR spectra of compounds 5a, 5b, 5d, and 5e appeared a similar splitting patterns and chemical shifts as shown in compound 5c but only differed in term of the number of protons and carbons in the alkyl chains. Compounds 5f–j attached with small substituents such as hydroxy, carboxy, chloro, nitro, and amino at the terminal end showed a singlet of amide signal and six doublets for aromatic protons in the 1H NMR spectra.
Both 1H and 13C NMR spectra of these compounds showed a slight difference in the chemical shift values, which due to the chemical environment, electronegativity effect, and bond angles. Meanwhile, compounds 5f and 5g displayed an additional signal for hydroxyl and carboxyl proton peaks in the 1H NMR spectra. Moreover, all the compounds in this series showed a singlet in the 31P NMR spectrum due to hexa-substituted in the arms (Fig. 5).
| Compound | Mode | Transition temperature (°C), enthalpy, ΔH (kJ mol−1) | ||||
|---|---|---|---|---|---|---|
| a Cr = crystal, SmA = smectic A, I = isotropic. | ||||||
| 5a | Heating | Cr | 188.02, 186.54 | SmA | 286.83, 48.13 | I |
| Cooling | I | 280.47, −58.43 | SmA | 170.05, −212.30 | Cr | |
| 5b | Heating | Cr | 177.09, 173.10 | SmA | 287.87, 68.64 | I |
| Cooling | I | 282.57, −73.98 | SmA | 161.53, −207.61 | Cr | |
| 5c | Heating | Cr | 174.44, 156.52 | SmA | 286.15, 70.96 | I |
| Cooling | I | 278.75, −77.83 | SmA | 158.16, −204.07 | Cr | |
| 5d | Heating | Cr | 171.44, 191.73 | SmA | 281.61, 83.37 | I |
| Cooling | I | 275.76, −88.98 | SmA | 155.73, −211.63 | Cr | |
| 5e | Heating | Cr | 168.58, 125.75 | SmA | 276.25, 76.22 | I |
| Cooling | I | 267.13, −76.78 | SmA | 149.00, −182.89 | Cr | |
The DSC thermograms of compounds 5a–e showed two curves for the transition of crystal to SmA and to isotropic phase in both cycles. All compounds showed high melting and clearing temperature in the heating cycle. From the DSC data, the melting temperature was observed at 188.02, 177.09, 174.44, 171.44, and 168.58 °C, which corresponded to compounds 5a–e, respectively. The DSC thermogram of compound 5c was illustrated in Fig. 7. The melting and clearing temperature of the compounds showed similar pattern whereby the temperature decreased as the number of alkyl chains increased. As reported by Moriya et al. (2006), the melting and clearing temperature decreased with an increased number of alkyl chains.26 Moreover, all the compounds have high enthalpy changes at the clearing temperature. This behaviour was related to the high molecular weight of hexasubstituted cyclotriphosphazene compounds, which effected by their π-energy, hydrogen-bonding and van der Waals forces.27
| XRD data analysis | Value |
|---|---|
| 2 theta | 1.93 |
| d-Layer spacing | 45.74 |
| Molecular length (L) | 41.23 |
| Calculated d/L | 1.11 |
| Arrangement of SmA | Monolayer |
The main criteria for a molecule to adopt liquid crystal behaviour include the molecular shape which should be relatively thin or flat within rigid molecular frameworks, which usually based on benzene rings.31 In general, terminal group which extends the molecular long axis without increasing the molecular width increase the thermal stability of the mesophase. The nature of the terminal substituents or end groups in the molecule of the mesogen has profound influence on the liquid crystal properties of the compound. There are varieties of terminal groups being employed in the liquid crystal molecules and the common groups vary from a small polar substituent (e.g. chloro or nitro) to a long chain (e.g. alkyl or alkoxy).32 The choice of a terminal group is very important to generate the expected liquid crystal mesophase in a molecule.
Most of the molecules consist of one terminal alkyl chain showed liquid crystal behaviour. This was proven when all the final compounds (5a–e) with the alkoxy chains at the terminal end exhibited the smectic A phase in both cooling and heating cycles. The length of the alkoxy side chain showed strong influence on the mesophase formation.33 Longer alkoxy chains induced the liquid crystal behaviour with broader temperature ranges as well as decreased melting temperatures, Tm.34 In addition, the number of alkoxy side chains greatly affect molecular self-assembly.35 Besides, the long alkyl chains add flexibility to the rigid core and stabilize the molecular interactions needed for the formation of liquid crystal mesophase.34
Conjugation within the Schiff base moiety led to possible of controlling the alignment and orientation of their molecules to generate liquid crystal properties.36 Schiff base linking unit provide a stepped core structure which can maintain the molecular linearity.32 This linearity provides high stability and enabling mesophase formation. However, all compounds (5f–j) with small substituent such as hydroxy, carboxy, chloro, nitro, and amino groups at the terminal end were found to be non-mesogenic. Kelker and Hatz reported the behaviour of the small substituent at the terminal end do not always form liquid crystal phases.33,35 The lone pair of electrons or π bonds in compounds 5f and 5g tend to resonate onto the aromatic ring which resulted in the cancellation of dipole moments of the molecules.36,37 As a result, the formation of the mesophase in the molecules cannot be induced.
Even though compound 5h and 5i attached with polar substituent, which possesses strong dipole moment, the presence of the amide linking unit resulted in high melting temperature and the mesophase cannot be observed.16 Compound 5j did not exhibited any liquid crystal character due to the properties of the NH2 as an electron donating group, which maximise the repulsive interactions between adjacent aromatic rings and caused the tendency for formation of the mesophase was reduced.38 The POM observation of compounds 5a–j are summarized in Table 3.
| Compound | Terminal substituent | POM observation | |
|---|---|---|---|
| 5a | Heptyloxy | (–OC7H15) | Smectic A |
| 5b | Nonyloxy | (–OC9H19) | Smectic A |
| 5c | Decyloxy | (–OC10H21) | Smectic A |
| 5d | Dodecyloxy | (–OC12H25) | Smectic A |
| 5e | Tetradecyl | (–OC14H29) | Smectic A |
| 5f | Hydroxy | (–OH) | Non-mesogenic |
| 5g | Carboxy | (–COOH) | Non-mesogenic |
| 5h | Chloro | (–Cl) | Non-mesogenic |
| 5i | Nitro | (–NO2) | Non-mesogenic |
| 5j | Amino | (–NH2) | Non-mesogenic |
The sample was prepared by mixing 1 wt% of the final compound with polyester resin. About 1 wt% of methyl ethyl ketone peroxide (MEKP) curing agent was added to the mixture and stirred until the sample is homogeneous and then poured into the moulds. The samples were cured for 5 hours in an oven at 60 °C and left overnight at room temperature before it was burned using LOI testing. The LOI test was performed using an FTT oxygen index, according to BS 2782: Part 1: Method 141 and ISO 4589 with the dimension of 120 mm × 10 mm × 4 mm.
According to LOI data in Table 4, pure polyester resin has the LOI value of 22.53%. The LOI value of polyester resin was increased to 24.71% when incorporated with 1 wt% of HCCP. Schiff base linking units was found to enhance the properties of fire-retardant. This phenomenon was attributed to the high thermal stability of the Schiff base molecules, which promoted the formation of char on the surface in the condensed phase.39 Interestingly, when Schiff base unit was combined with an amide unit, the LOI values showed a slight increase. This positive result was attributed to the properties of the electron withdrawing group of the amide bond which enhanced the flammability properties of the compounds.40,41 As a result, all the compounds have high LOI value, indicating these compounds have high thermal stability and fire retardancy. Compound 5i showed the highest LOI value compared to other compounds due to the effect of electron withdrawing of nitro group which enhance the synergistic effect of P–N bonds.42 This behaviour caused the compounds exhibited both condensed and gas phase action and thus, prevents the sample from further burning. Hence, these compounds possessed highest LOI value.
| Material | LOI value (%) |
|---|---|
| Pure polyester resin | 22.53 (±0.00) |
| Polyester resin + 1 wt% of HCCP | 24.71 (±0.00) |
| Compound 5a | 27.90 (±0.00) |
| Compound 5b | 27.71 (±0.00) |
| Compound 5c | 27.71 (±0.00) |
| Compound 5d | 27.55 (±0.00) |
| Compound 5e | 27.53 (±0.00) |
| Compound 5f | 28.37 (±0.00) |
| Compound 5g | 27.93 (±0.04) |
| Compound 5h | 28.42 (±0.00) |
| Compound 5i | 28.53 (±0.00) |
| Compound 5j | 27.90 (±0.00) |
1699 (C
O stretching), 1595 (C
C stretching), 1205 (C–O stretching), 1151 (P
N stretching), 944 (P–O–C stretching). 1H-NMR (500 MHz, DMSO-d6) δ, ppm: 9.90 (s, 1H), 7.78 (d, J = 10.0 Hz, 2H), 7.16 (d, J = 10.0 Hz, 2H). 13C-NMR (125 MHz, DMSO-d6) δ, ppm: 191.69, 153.59, 133.55, 131.46, 121.03. 31P-NMR (500 MHz, DMSO-d6) δ, ppm: 7.60 (s, 1P). CHN elemental analysis: calculated for C42H30N3O12P3: C: 58.55%, H: 3.51%, N: 4.88%; found: C: 58.28%, H: 3.48%, N: 4.83%.
O stretching), 1607 (aromatic C
C stretching), 1252 (C–O stretching). 1H-NMR (500 MHz, CDCl3) δ, ppm: 7.78 (d, J = 5.0 Hz, 2H), 6.73 (d, J = 10.0 Hz, 2H), 3.96 (t, J = 7.5 Hz, 2H), 1.68–1.74 (m, 2H), 1.40–1.46 (m, 2H), 1.27–1.38 (m, 6H), 0.89 (t, J = 7.5 Hz, 3H). 13C-NMR (125 MHz, CDCl3) δ, ppm: 168.78, 158.91, 135.20, 130.31, 112.80, 67.73, 31.09, 28.83, 28.28, 25.44, 21.82, 13.60. CHN elemental analysis: calculated for C14H20O3: C: 71.16%, H: 8.53%; found: C: 71.01%, H: 8.57%.
O stretching), 1606 (aromatic C
C stretching), 1252 (C–O stretching). 1H-NMR (500 MHz, CDCl3) δ, ppm: 7.80 (d, J = 10.0 Hz, 2H), 6.74 (d, J = 5.0 Hz, 2H), 3.97 (t, J = 5.0 Hz, 2H), 1.69–1.74 (m, 2H), 1.41–1.47 (m, 2H), 1.27–1.39 (m, 10H), 0.88 (t, J = 5.0 Hz, 3H). 13C-NMR (125 MHz, CDCl3) δ, ppm: 169.36, 159.16, 134.83, 130.37, 113.02, 67.95, 31.10, 28.84, 28.76, 28.62, 28.39, 25.46, 21.80, 13.48. CHN elemental analysis: calculated for C16H24O3: C: 72.69%, H: 9.15%; found: C: 71.95%, H: 9.15%.
O stretching), 1606 (aromatic C
C stretching), 1251 (C–O stretching). 1H-NMR (500 MHz, CDCl3) δ, ppm: 7.78 (d, J = 10.0 Hz, 2H), 6.73 (d, J = 10.0 Hz, 2H), 3.96 (t, J = 5.0 Hz, 2H), 1.68–1.73 (m, 2H), 1.40–1.46 (m, 2H), 1.26–1.36 (m, 12H), 0.87 (t, J = 7.5 Hz, 3H). 13C-NMR (125 MHz, CDCl3) δ, ppm: 168.78, 159.00, 134.78, 130.36, 112.83, 67.73, 31.13, 28.82, 28.80, 28.77, 28.63, 28.47, 25.45, 21.85, 13.60. CHN elemental analysis: calculated for C17H26O3: C: 73.35%, H: 9.41%; found: C: 73.14%, H: 9.35%.
O stretching), 1603 (aromatic C
C stretching), 1250 (C–O stretching). 1H-NMR (500 MHz, CDCl3) δ, ppm: 7.83 (d, J = 5.0 Hz, 2H), 6.84 (d, J = 10.0 Hz, 2H), 4.00 (t, J = 7.5 Hz, 2H), 1.69–1.75 (m, 2H), 1.40–1.44 (m, 2H), 1.26–1.35 (m, 16H), 0.87 (t, J = 5.0 Hz, 3H). 13C-NMR (125 MHz, CDCl3) δ, ppm: 167.95, 160.55, 134.78, 130.75, 113.53, 67.88, 31.13, 28.83, 28.81, 28.79, 28.78, 28.67, 28.58, 28.47, 25.39, 21.85, 13.59. CHN elemental analysis: calculated for C19H30O3: C: 74.47%, H: 9.87%; found: C: 73.74%, H: 9.98%.
O stretching), 1607 (aromatic C
C stretching), 1252 (C–O stretching). 1H-NMR (500 MHz, CDCl3) δ, ppm: 7.80 (d, J = 5.0 Hz, 2H), 6.74 (d, J = 10.0 Hz, 2H), 3.97 (t, J = 5.0 Hz, 2H), 1.68–1.74 (m, 2H), 1.40–1.46 (m, 2H), 1.20–1.36 (m, 20H), 0.87 (t, J = 7.5 Hz, 3H). 13C-NMR (125 MHz, CDCl3) δ, ppm: 169.18, 159.27, 134.27, 130.42, 113.02, 67.91, 31.11, 28.83, 28.82, 28.81, 28.80, 28.79, 28.77, 28.76, 28.59, 28.44, 25.44, 21.80, 13.49. CHN elemental analysis: calculated for C21H34O3: C: 75.41%, H: 10.25%; found: C: 74.51%, H: 10.15%.
O stretching), 1598 (aromatic C
C stretching), 1248 (C–O stretching), 1176 (C–N stretching). 1H-NMR (500 MHz, CDCl3) δ, ppm: 10.61 (s, 1H), 8.23 (d, J = 5.0 Hz, 2H), 8.03 (d, J = 5.0 Hz, 2H), 7.95 (d, J = 10.0 Hz, 2H), 7.04 (d, J = 10.0 Hz, 2H), 4.03 (t, J = 7.5 Hz, 2H), 1.68–1.74 (m, 2H), 1.36–1.42 (m, 2H), 1.23–1.33 (m, 6H), 0.85 (t, J = 7.5 Hz, 3H). 13C-NMR (125 MHz, CDCl3) δ, ppm: 166.15, 162.59, 146.09, 143.42, 130.26, 126.95, 124.78, 120.56, 115.03, 68.82, 31.51, 29.08, 28.66, 25.81, 22.22, 13.94. CHN elemental analysis: calculated for C20H24N2O4: C: 67.40%, H: 6.79%, N: 7.86%; found: C: 66.81%, H: 6.84%, N: 7.77%.
O stretching), 1601 (aromatic C
C stretching), 1248 (C–O stretching), 1176 (C–N stretching). 1H-NMR (500 MHz, CDCl3) δ, ppm: 10.22 (s, 1H), 8.18 (d, J = 10.0 Hz, 2H), 8.00 (d, J = 10.0 Hz, 2H), 7.96 (d, J = 10.0 Hz, 2H), 7.03 (d, J = 10.0 Hz, 2H), 4.09 (t, J = 5.0 Hz, 2H), 1.73–1.78 (m, 2H), 1.42–1.48 (m, 2H), 1.25–1.39 (m, 10H), 0.87 (t, J = 7.5 Hz, 3H). 13C-NMR (125 MHz, CDCl3) δ, ppm: 166.26, 162.50, 145.95, 143.26, 130.27, 126.65, 124.87, 120.56, 114.93, 68.66, 31.54, 29.17, 29.00, 28.95, 28.83, 25.77, 22.29, 14.04. CHN elemental analysis: calculated for C22H28N2O4: C: 68.73%, H: 7.34%, N: 7.29%; found: C: 68.03%, H: 7.39%, N: 7.27%.
O stretching), 1598 (aromatic C
C stretching), 1246 (C–O stretching), 1176 (C–N stretching). 1H-NMR (500 MHz, CDCl3) δ, ppm: 10.33 (s, 1H), 8.19 (d, J = 10.0 Hz, 2H), 8.00 (d, J = 5.0 Hz, 2H), 7.95 (d, J = 5.0 Hz, 2H), 7.03 (d, J = 10.0 Hz, 2H), 4.07 (t, J = 7.5 Hz, 2H), 1.70–1.76 (m, 2H), 1.39–1.45 (m, 2H), 1.22–1.36 (m, 12H), 0.85 (t, J = 7.5 Hz, 3H). 13C-NMR (125 MHz, CDCl3) δ, ppm: 166.18, 162.51, 146.05, 143.24, 130.29, 126.72, 124.89, 120.52, 114.93, 68.66, 31.59, 29.24, 29.20, 29.02, 28.99, 28.92, 25.80, 22.32, 14.07. CHN elemental analysis: calculated for C23H30N2O4: C: 69.32%, H: 7.59%, N: 7.03%; found: C: 69.12%, H: 7.59%, N: 6.99%.
O stretching), 1598 (aromatic C
C stretching), 1248 (C–O stretching), 1176 (C–N stretching). 1H-NMR (500 MHz, CDCl3) δ, ppm: 10.25 (s, 1H), 8.16 (d, J = 10.0 Hz, 2H), 7.96 (d, J = 5.0 Hz, 2H), 7.92 (d, J = 10.0 Hz, 2H), 7.00 (d, J = 10.0 Hz, 2H), 4.05 (t, J = 5.0 Hz, 2H), 1.68–1.74 (m, 2H), 1.37–1.43 (m, 2H), 1.19–1.34 (m, 16H), 0.82 (t, J = 5.0 Hz, 3H). 13C-NMR (125 MHz, CDCl3) δ, ppm: 166.31, 162.52, 146.90, 143.32, 130.24, 126.65, 124.86, 120.61, 114.97, 68.69, 31.54, 29.23, 29.22, 29.18, 29.16, 29.15, 28.93, 28.88, 25.74, 22.27, 13.99. CHN elemental analysis: calculated for C25H34N2O4: C: 70.40%, H: 8.03%, N: 6.57%; found: C: 70.06%, H: 8.03%, N: 6.50%.
O stretching), 1606 (aromatic C
C stretching), 1254 (C–O stretching), 1178 (C–N stretching). 1H-NMR (500 MHz, CDCl3) δ, ppm: 10.25 (s, 1H), 8.17 (d, J = 5.0 Hz, 2H), 7.96 (d, J = 5.0 Hz, 2H), 7.92 (d, J = 10.0 Hz, 2H), 7.01 (d, J = 5.0 Hz, 2H), 4.05 (t, J = 5.0 Hz, 2H), 1.69–1.74 (m, 2H), 1.37–1.43 (m, 2H), 1.17–1.36 (m, 20H), 0.82 (t, J = 5.0 Hz, 3H). 13C-NMR (125 MHz, CDCl3) δ, ppm: 166.32, 162.53, 146.91, 143.33, 130.25, 126.66, 124.86, 120.61, 114.98, 68.70, 31.55, 29.25, 29.23, 29.22, 29.19, 29.18, 29.16, 29.15, 28.94, 28.89, 25.75, 22.28, 14.00. CHN elemental analysis: calculated for C27H38N2O4: C: 71.34%, H: 8.43%, N: 6.16%; found: C: 70.68%, H: 8.38%, N: 6.12%.
O stretching), 1600 (aromatic C
C stretching), 1252 (C–O stretching), 1175 (C–N stretching). 1H-NMR (500 MHz, CDCl3) δ, ppm: 9.72 (s, 1H), 8.04 (d, J = 5.0 Hz, 2H), 7.71 (d, J = 10.0 Hz, 2H), 6.90 (d, J = 5.0 Hz, 2H), 6.88 (d, J = 10.0 Hz, 2H). 13C-NMR (125 MHz, CDCl3) δ, ppm: 166.77, 162.55, 146.89, 143.12, 130.75, 125.80, 124.47, 120.50, 113.96. CHN elemental analysis: calculated for C13H10N2O4: C: 60.47%, H: 3.90%, N: 10.85%; found: C: 60.10%, H: 3.88%, N: 10.79%.
O stretching), 1606 (aromatic C
C stretching), 1248 (C–O stretching), 1177 (C–N stretching). 1H-NMR (500 MHz, CDCl3) δ, ppm: 11.06 (s, 1H), 10.07 (s, 1H), 8.10 (d, J = 10.0 Hz, 2H), 8.08 (d, J = 5.0 Hz, 2H), 7.98 (d, J = 10.0 Hz, 2H), 6.90 (d, J = 10.0 Hz, 2H). 13C-NMR (125 MHz, CDCl3) δ, ppm: 167.03, 164.33, 140.06, 139.29, 136.08, 130.55, 130.34, 129.94, 126.57, 116.19. CHN elemental analysis: calculated for C14H10N2O5: C: 58.75%, H: 3.52%, N: 9.79%; found: C: 58.43%, H: 3.50%, N: 9.80%.
O stretching), 1602 (aromatic C
C stretching), 1250 (C–O stretching), 1170 (C–N stretching), 827 (C–Cl bending). 1H-NMR (500 MHz, CDCl3) δ, ppm: 9.90 (s, 1H), 8.02 (d, J = 10.0 Hz, 2H), 7.83 (d, J = 10.0 Hz, 2H), 7.55 (d, J = 5.0 Hz, 2H), 6.87 (d, J = 5.0 Hz, 2H). 13C-NMR (125 MHz, CDCl3) δ, ppm: 166.58, 162.51, 146.91, 143.21, 130.69, 125.84, 124.57, 121.22, 117.10. CHN elemental analysis: calculated for C13H9ClN2O3: C: 56.44%, H: 3.28%, N: 12.81%; found: C: 56.27%, H: 3.25%, N: 12.76%.
O stretching), 1609 (aromatic C
C stretching), 1254 (C–O stretching), 1173 (C–N stretching). 1H-NMR (500 MHz, CDCl3) δ, ppm: 9.69 (s, 1H), 7.89 (d, J = 5.0 Hz, 2H), 7.34 (d, J = 5.0 Hz, 2H), 7.00 (d, J = 5.0 Hz, 2H), 6.53 (d, J = 10.0 Hz, 2H), 4.87 (s, 2H), 4.02 (t, J = 5.0 Hz, 2H), 1.69–1.75 (m, 2H), 1.38–1.44 (m, 2H), 1.25–1.36 (m, 6H), 0.86 (t, J = 7.5 Hz, 3H). 13C-NMR (125 MHz, CDCl3) δ, ppm: 164.64, 161.46, 145.46, 129.72, 128.76, 127.64, 122.74, 114.38, 114.17, 68.15, 31.68, 29.05, 28.87, 25.90, 22.50, 14.40. CHN elemental analysis: calculated for C20H26N2O2: C: 73.59%, H: 8.03%, N: 8.58%; found: C: 73.26%, H: 8.08%, N: 8.51%.
O stretching), 1609 (aromatic C
C stretching), 1254 (C–O stretching), 1178 (C–N stretching). 1H-NMR (500 MHz, CDCl3) δ, ppm: 9.69 (s, 1H), 7.88 (d, J = 10.0 Hz, 2H), 7.33 (d, J = 10.0 Hz, 2H), 6.99 (d, J = 10.0 Hz, 2H), 6.53 (d, J = 10.0 Hz, 2H), 4.87 (s, 2H), 4.02 (t, J = 5.0 Hz, 2H), 1.69–1.74 (m, 2H), 1.38–1.43 (m, 2H), 1.22–1.35 (m, 10H), 0.85 (t, J = 5.0 Hz, 3H). 13C-NMR (125 MHz, CDCl3) δ, ppm: 164.64, 161.46, 145.46, 129.72, 128.75, 127.63, 122.75, 114.38, 114.18, 68.15, 31.72, 29.40, 29.21, 29.09, 29.04, 25.92, 22.55, 14.41. CHN elemental analysis: calculated for C22H30N2O2: C: 74.54%, H: 8.53%, N: 7.90%; found: C: 74.31%, H: 8.54%, N: 7.88%.
O stretching), 1606 (aromatic C
C stretching), 1254 (C–O stretching), 1176 (C–N stretching). 1H-NMR (500 MHz, CDCl3) δ, ppm: 9.68 (s, 1H), 7.89 (d, J = 10.0 Hz, 2H), 7.34 (d, J = 10.0 Hz, 2H), 7.00 (d, J = 10.0 Hz, 2H), 6.53 (d, J = 10.0 Hz, 2H), 4.87 (s, 2H), 4.03 (t, J = 7.5 Hz, 2H), 1.69–1.75 (m, 2H), 1.38–1.44 (m, 2H), 1.22–1.35 (m, 12H), 0.86 (t, J = 7.5 Hz, 3H). 13C-NMR (125 MHz, CDCl3) δ, ppm: 164.57, 161.45, 145.48, 129.72, 128.77, 127.69, 122.73, 114.38, 114.15, 68.15, 31.75, 29.45, 29.40, 29.21, 29.15, 29.05, 25.93, 22.55, 14.42. CHN elemental analysis: calculated for C23H32N2O2: C: 74.96%, H: 8.75%, N: 7.60%; found: C: 74.65%, H: 8.75%, N: 7.57%.
O stretching), 1606 (aromatic C
C stretching), 1254 (C–O stretching), 1178 (C–N stretching). 1H-NMR (500 MHz, CDCl3) δ, ppm: 9.69 (s, 1H), 7.89 (d, J = 10.0 Hz, 2H), 7.34 (d, J = 10.0 Hz, 2H), 7.00 (d, J = 5.0 Hz, 2H), 6.53 (d, J = 10.0 Hz, 2H), 4.87 (s, 2H), 4.02 (t, J = 7.5 Hz, 2H), 1.69–1.75 (m, 2H), 1.38–1.44 (m, 2H), 1.22–1.34 (m, 16H), 0.85 (t, J = 5.0 Hz, 3H). 13C-NMR (125 MHz, CDCl3) δ, ppm: 164.62, 161.45, 145.47, 129.72, 128.77, 127.65, 122.74, 114.37, 114.16, 68.14, 31.75, 29.48, 29.46, 29.44, 29.43, 29.19, 29.16, 29.04, 25.92, 22.55, 14.41. CHN elemental analysis: calculated for C25H36N2O2: C: 75.72%, H: 9.15%, N: 7.06%; found: C: 75.56%, H: 9.13%, N: 7.01%.
O stretching), 1606 (aromatic C
C stretching), 1256 (C–O stretching), 1176 (C–N stretching). 1H-NMR (500 MHz, CDCl3) δ, ppm: 9.31 (s, 1H), 7.88 (d, J = 10.0 Hz, 2H), 7.34 (d, J = 10.0 Hz, 2H), 6.98 (d, J = 5.0 Hz, 2H), 6.59 (d, J = 5.0 Hz, 2H), 4.06 (t, J = 7.5 Hz, 2H), 1.73–1.77 (m, 2H), 1.41–1.46 (m, 2H), 1.25–1.38 (m, 20H), 0.87 (t, J = 7.5 Hz, 3H). 13C-NMR (125 MHz, CDCl3) δ, ppm: 164.94, 161.69, 145.25, 131.67, 129.63, 129.39, 122.94, 114.74, 114.60, 68.65, 31.62, 29.34, 29.33, 29.31, 29.27, 29.26, 29.24, 29.12, 29.06, 28.96, 25.86, 22.31, 14.02. CHN elemental analysis: calculated for C27H40N2O2: C: 76.37%, H: 9.50%, N: 6.60%; found: C: 76.18%, H: 9.47%, N: 6.62%.
O stretching), 1609 (aromatic C
C stretching), 1254 (C–O stretching), 1178 (C–N stretching). 1H-NMR (500 MHz, CDCl3) δ, ppm: 9.73 (s, 1H), 8.24 (d, J = 5.0 Hz, 2H), 8.10 (d, J = 10.0 Hz, 2H), 7.71 (d, J = 10.0 Hz, 2H), 6.89 (d, J = 10.0 Hz, 2H). 13C-NMR (125 MHz, CDCl3) δ, ppm: 166.28, 163.72, 150.37, 136.75, 132.54, 131.07, 128.83, 124.02, 116.26. CHN elemental analysis: calculated for C13H12N2O2: C: 68.41%, H: 5.30%, N: 12.27%; found: C: 68.17%, H: 5.27%, N: 12.19%.
O stretching), 1608 (aromatic C
C stretching), 1254 (C–O stretching), 1178 (C–N stretching). 1H-NMR (500 MHz, CDCl3) δ, ppm: 10.06 (s, 1H), 8.10 (d, J = 10.0 Hz, 2H), 7.98 (d, J = 5.0 Hz, 2H), 7.92 (d, J = 10.0 Hz, 2H), 6.67 (s, 2H), 6.60 (d, J = 10.0 Hz, 2H). 13C-NMR (125 MHz, CDCl3) δ, ppm: 167.07, 156.08, 139.27, 136.17, 136.11, 130.34, 129.94, 126.81, 112.86. CHN elemental analysis: calculated for C14H12N2O3: C: 65.62%, H: 4.72%, N: 10.93%; found: C: 65.28%, H: 4.70%, N: 10.85%.
O stretching), 1701 (aromatic C
C stretching), 1252 (C–O stretching), 1189 (C–N stretching), 825 (C–Cl bending). 1H-NMR (500 MHz, CDCl3) δ, ppm: 10.08 (s, 1H), 8.33 (d, J = 5.0 Hz, 2H), 8.09 (d, J = 10.0 Hz, 2H), 7.88 (d, J = 10.0 Hz, 2H), 6.61 (s, 2H), 6.58 (d, J = 10.0 Hz, 2H). 13C-NMR (125 MHz, CDCl3) δ, ppm: 166.87, 163.80, 150.45, 136.76, 132.60, 131.29, 128.90, 124.33, 118.11. CHN elemental analysis: calculated for C13H11ClN2O: C: 63.29%, H: 4.49%, N: 14.37%; found: C: 63.12%, H: 4.50%, N: 14.26%.
O stretching), 1595 (aromatic C
C stretching), 1248 (C–O stretching), 1146 (C–N stretching). 1H-NMR (500 MHz, CDCl3) δ, ppm: 9.93 (s, 1H), 7.90 (d, J = 10.0 Hz, 2H), 7.87 (d, J = 5.0 Hz, 2H), 7.59 (d, J = 6.0 Hz, 2H), 6.63 (s, 2H), 6.59 (d, J = 10.0 Hz, 2H). 13C-NMR (125 MHz, CDCl3) δ, ppm: 166.59, 162.98, 150.10, 136.44, 132.37, 131.10, 128.51, 123.89, 114.70. CHN elemental analysis: calculated for C14H12N2O3: C: 65.62%, H: 4.72%, N: 10.93%; found: C: 65.34%, H: 4.69%, N: 10.82%.
O stretching), 1644 (C
N stretching), 1592 (aromatic C
C stretching), 1254 (C–O stretching), 1197 (P
N stretching), 1178 (C–N stretching), 977 (P–O–C stretching). 1H-NMR (500 MHz, DMSO-d6) δ, ppm: 9.83 (s, 1H), 8.65 (s, 1H), 7.95 (d, J = 5.0 Hz, 2H), 7.94 (d, J = 5.0 Hz, 2H), 7.80 (d, J = 10.0 Hz, 2H), 7.55 (d, J = 5.0 Hz, 2H), 7.29 (d, J = 10.0 Hz, 2H), 7.02 (d, J = 10.0 Hz, 2H), 4.08 (t, J = 5.0 Hz, 2H), 1.73–1.79 (m, 2H), 1.42–1.48 (m, 2H), 1.28–1.40 (m, 6H), 0.89 (t, J = 5.0 Hz, 3H). 13C-NMR (125 MHz, DMSO-d6) δ, ppm: 165.46, 162.05, 158.11, 146.97, 138.44, 136.35, 135.82, 130.48, 129.94, 129.29, 127.70, 121.74, 121.69, 114.82, 68.65, 31.56, 29.11, 28.71, 25.85, 22.29, 14.06. 31P-NMR (500 MHz, DMSO-d6) δ, ppm: 8.49 (s, 1P). CHN elemental analysis: calculated for C162H174N15O18P3: C: 71.74%, H: 6.47%, N: 7.75%; found: C: 71.57%, H: 6.40%, N: 7.71%.
O stretching), 1646 (C
N stretching), 1593 (aromatic C
C stretching), 1256 (C–O stretching), 1197 (P
N stretching), 1178 (C–N stretching), 974 (P–O–C stretching). 1H-NMR (500 MHz, DMSO-d6) δ, ppm: 9.82 (s, 1H), 8.65 (s, 1H), 7.96 (d, J = 10.0 Hz, 2H), 7.94 (d, J = 10.0 Hz, 2H), 7.81 (d, J = 10.0 Hz, 2H), 7.54 (d, J = 10.0 Hz, 2H), 7.29 (d, J = 10.0 Hz, 2H), 7.02 (d, J = 10.0 Hz, 2H), 4.08 (t, J = 7.5 Hz, 2H), 1.73–1.79 (m, 2H), 1.42–1.48 (m, 2H), 1.24–1.39 (m, 10H), 0.88 (t, J = 5.0 Hz, 3H). 13C-NMR (125 MHz, DMSO-d6) δ, ppm: 165.44, 162.05, 158.04, 146.95, 138.46, 136.36, 135.82, 130.46, 129.94, 129.27, 127.71, 121.74, 121.69, 114.80, 68.64, 31.63, 29.28, 29.11, 28.93, 25.89, 22.36, 14.08. 31P-NMR (500 MHz, DMSO-d6) δ, ppm: 8.51 (s, 1P). CHN elemental analysis: calculated for C174H198N15O18P3: C: 72.55%, H: 6.93%, N: 7.29%; found: C: 72.04%, H: 6.88%, N: 7.22%.
O stretching), 1644 (C
N stretching), 1593 (aromatic C
C stretching), 1259 (C–O stretching), 1197 (P
N stretching), 1181 (C–N stretching), 977 (P–O–C stretching). 1H-NMR (500 MHz, DMSO-d6) δ, ppm: 9.82 (s, 1H), 8.65 (s, 1H), 7.96 (d, J = 10.0 Hz, 2H), 7.94 (d, J = 5.0 Hz, 2H), 7.80 (d, J = 10.0 Hz, 2H), 7.55 (d, J = 5.0 Hz, 2H), 7.29 (d, J = 10.0 Hz, 2H), 7.03 (d, J = 5.0 Hz, 2H), 4.08 (t, J = 7.5 Hz, 2H), 1.73–1.78 (m, 2H), 1.42–1.48 (m, 2H), 1.24–1.38 (m, 12H), 0.88 (t, J = 7.5 Hz, 3H). 13C-NMR (125 MHz, DMSO-d6) δ, ppm: 165.46, 162.05, 158.10, 146.96, 138.43, 136.36, 135.81, 130.47, 129.94, 129.28, 127.69, 121.75, 121.69, 114.81, 68.64, 31.63, 29.30, 29.26, 29.09, 28.97, 25.87, 22.34, 14.07. 31P-NMR (500 MHz, DMSO-d6) δ, ppm: 8.48 (s, 1P). CHN elemental analysis: calculated for C180H210N15O18P3: C: 72.92%, H: 7.14%, N: 7.09%; found: C: 72.76%, H: 7.11%, N: 7.02%.
O stretching), 1644 (C
N stretching), 1592 (aromatic C
C stretching), 1255 (C–O stretching), 1197 (P
N stretching), 1178 (C–N stretching), 978 (P–O–C stretching). 1H-NMR (500 MHz, DMSO-d6) δ, ppm: 9.82 (s, 1H), 8.65 (s, 1H), 7.95 (d, J = 10.0 Hz, 2H), 7.94 (d, J = 5.0 Hz, 2H), 7.80 (d, J = 10.0 Hz, 2H), 7.54 (d, J = 10.0 Hz, 2H), 7.29 (d, J = 10.0 Hz, 2H), 7.02 (d, J = 10.0 Hz, 2H), 4.07 (t, J = 7.5 Hz, 2H), 1.72–1.78 (m, 2H), 1.42–1.48 (m, 2H), 1.24–1.37 (m, 16H), 0.87 (t, J = 7.5 Hz, 3H). 13C-NMR (125 MHz, DMSO-d6) δ, ppm: 165.46, 162.04, 158.07, 146.96, 138.42, 136.36, 135.80, 130.46, 129.93, 129.27, 127.68, 121.75, 121.68, 114.80, 68.63, 31.63, 29.35, 29.32, 29.29, 29.09, 29.08, 28.98, 25.87, 22.34, 14.06. 31P-NMR (500 MHz, DMSO-d6) δ, ppm: 8.50 (s, 1P). CHN elemental analysis: calculated for C192H234N15O18P3: C: 73.61%, H: 7.53%, N: 6.71%; found: C: 73.23%, H: 7.48%, N: 6.65%.
O stretching), 1641 (C
N stretching), 1599 (aromatic C
C stretching), 1259 (C–O stretching), 1189 (P
N stretching), 1178 (C–N stretching), 977 (P–O–C stretching). 1H-NMR (500 MHz, DMSO-d6) δ, ppm: 9.82 (s, 1H), 8.64 (s, 1H), 7.95 (d, J = 10.0 Hz, 2H), 7.94 (d, J = 5.0 Hz, 2H), 7.81 (d, J = 5.0 Hz, 2H), 7.54 (d, J = 5.0 Hz, 2H), 7.29 (d, J = 10.0 Hz, 2H), 7.02 (d, J = 5.0 Hz, 2H), 4.07 (t, J = 7.5 Hz, 2H), 1.72–1.78 (m, 2H), 1.42–1.47 (m, 2H), 1.22–1.38 (m, 20H), 0.87 (t, J = 7.5 Hz, 3H). 13C-NMR (125 MHz, DMSO-d6) δ, ppm: 165.44, 162.04, 158.04, 146.95, 138.44, 136.36, 135.81, 130.45, 129.93, 129.27, 127.69, 121.74, 121.67, 114.79, 68.63, 31.64, 29.37, 29.36, 29.35, 29.34, 29.29, 29.11, 29.09, 28.97, 25.87, 22.34, 14.05. 31P-NMR (500 MHz, DMSO-d6) δ, ppm: 8.47 (s, 1P). CHN elemental analysis: calculated for C204H258N15O18P3: C: 74.22%, H: 7.88%, N: 6.36%; found: C: 73.89%, H: 7.80%, N: 6.31%.
O stretching), 1640 (C
N stretching), 1590 (aromatic C
C stretching), 1253 (C–O stretching), 1190 (P
N stretching), 1152 (C–N stretching), 980 (P–O–C stretching). 1H-NMR (500 MHz, DMSO-d6) δ, ppm: 8.42 (s, 1H), 7.94 (d, J = 5.0 Hz, 2H), 7.73 (d, J = 10.0 Hz, 2H), 7.50 (d, J = 10.0 Hz, 2H), 7.12 (d, J = 10.0 Hz, 2H), 6.88 (d, J = 10.0 Hz, 2H), 6.80 (d, J = 10.0 Hz, 2H). 13C-NMR (125 MHz, DMSO-d6) δ, ppm: 167.05, 160.60, 157.36, 156.14, 143.65, 138.25, 131.57, 130.67, 130.23, 129.09, 128.33, 122.59, 116.17, 116.07. 31P-NMR (500 MHz, DMSO-d6) δ, ppm: 8.52 (s, 1P). CHN elemental analysis: calculated for C120H90N15O18P3: C: 67.89%, H: 4.27%, N: 9.90%; found: C: 67.70%, H: 4.23%, N: 9.86%.
O stretching), 1642 (C
N stretching), 1601 (aromatic C
C stretching), 1254 (C–O stretching), 1190 (P
N stretching), 1174 (C–N stretching), 978 (P–O–C stretching). 1H-NMR (500 MHz, DMSO-d6) δ, ppm: 8.61 (s, 1H), 8.21 (d, J = 10.0 Hz, 2H), 8.10 (d, J = 5.0 Hz, 2H), 8.01 (d, J = 10.0 Hz, 2H), 7.94 (d, J = 5.0 Hz, 2H), 7.22 (d, J = 10.0 Hz, 2H), 6.82 (d, J = 5.0 Hz, 2H). 13C-NMR (125 MHz, DMSO-d6) δ, ppm: 167.47, 166.28, 157.21, 156.28, 150.29, 142.55, 140.52, 136.92, 131.02, 130.09, 128.60, 123.95, 123.19, 116.24. 31P-NMR (500 MHz, DMSO-d6) δ, ppm: 8.57 (s, 1P). CHN elemental analysis: calculated for C126H90N15O24P3: C: 66.05%, H: 3.96%, N: 9.17%; found: C: 65.81%, H: 3.94%, N: 9.09%.
O stretching), 1644 (C
N stretching), 1601 (aromatic C
C stretching), 1254 (C–O stretching), 1189 (P
N stretching), 1172 (C–N stretching), 1014 (P–O–C stretching), 819 (C–Cl bending). 1H-NMR (500 MHz, DMSO-d6) δ, ppm: 8.44 (s, 1H), 7.86 (d, J = 10.0 Hz, 2H), 7.77 (d, J = 10.0 Hz, 2H), 7.41 (d, J = 5.0 Hz, 2H), 7.39 (d, J = 10.0 Hz, 2H), 7.14 (d, J = 10.0 Hz, 2H), 6.79 (d, J = 10.0 Hz, 2H). 13C-NMR (125 MHz, DMSO-d6) δ, ppm: 167.36, 156.69, 156.48, 142.59, 138.31, 136.02, 135.30, 131.48, 130.20, 130.05, 129.18, 129.00, 123.00, 116.27. 31P-NMR (500 MHz, DMSO-d6) δ, ppm: 8.53 (s, 1P). CHN elemental analysis: calculated for C120H84Cl6N15O12P3: C: 64.53%, H: 3.79%, N: 9.42%; found: C: 64.13%, H: 3.77%, N: 9.38%.
O stretching), 1641 (C
N stretching), 1598 (aromatic C
C stretching), 1252 (C–O stretching), 1187 (P
N stretching), 1173 (C–N stretching), 1019 (P–O–C stretching). 1H-NMR (500 MHz, DMSO-d6) δ, ppm: 9.81 (s, 1H), 8.66 (s, 1H), 8.23 (d, J = 10.0 Hz, 2H), 8.04 (d, J = 10.0 Hz, 2H), 7.26 (d, J = 10.0 Hz, 2H), 6.82 (d, J = 10.0 Hz, 2H), 6.51 (d, J = 10.0 Hz, 2H), 6.46 (d, J = 10.0 Hz, 2H). 13C-NMR (125 MHz, DMSO-d6) δ, ppm: 157.63, 155.02, 148.82, 148.71, 142.42, 142.05, 140.85, 129.47, 124.29, 123.79, 123.56, 116.32, 116.06, 116.01. 31P-NMR (500 MHz, DMSO-d6) δ, ppm: 8.54 (s, 1P). CHN elemental analysis: calculated for C120H84N21O24P3: C: 62.75%, H: 3.69%, N: 12.81%; found: C: 62.33%, H: 3.65%, N: 12.69%.
O stretching), 1645 (C
N stretching), 1591 (aromatic C
C stretching), 1254 (C–O stretching), 1196 (P
N stretching), 1172 (C–N stretching), 1013 (P–O–C stretching). 1H-NMR (500 MHz, DMSO-d6) δ, ppm: 8.68 (s, 1H), 8.25 (d, J = 5.0 Hz, 2H), 8.06 (d, J = 5.0 Hz, 2H), 7.27 (d, J = 10.0 Hz, 2H), 6.99 (d, J = 5.0 Hz, 2H), 6.84 (d, J = 5.0 Hz, 2H), 6.56 (d, J = 10.0 Hz, 2H), 5.16 (s, 2H). 13C-NMR (125 MHz, DMSO-d6) δ, ppm: 157.67, 155.00, 148.73, 147.96, 142.47, 142.07, 129.64, 129.47, 128.94, 124.29, 123.56, 119.45, 116.32, 115.76. 31P-NMR (500 MHz, DMSO-d6) δ, ppm: 8.55 (s, 1P). CHN elemental analysis: calculated for C120H96N21O12P3: C: 68.08%, H: 4.57%, N: 13.89%; found: C: 67.77%, H: 4.59%, N: 13.79%.Footnote |
| † Electronic supplementary information (ESI) available: Fig. 1–5: DSC thermogram of compounds 5a–e, respectively. See DOI: 10.1039/d0ra03812a |
| This journal is © The Royal Society of Chemistry 2020 |